Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France

by P. Barthélémy, A. Thiery-Vuillemin, B. Escudier, J-C. Eymard, G. Mouillet, F. Schlürmann, M. Chartier, C. Quentric, Y-A. Vano, L. Albiges
Published 2020-11-01

IO-Synthesise RCC: A pooled analysis of real-world outcomes for advanced renal cell carcinoma patients treated with nivolumab in France and Germany

by A. Thiery-Vuillemin, J. Bedke, L. Albigès, P. Bigot, B. Escudier, E. von der Heyde, V. Grünwald, H. Müller-Huesmann, B. Narciso, M. Schostak, W. Schultze-Seemann, Y-A. Vano, V. Allan, M. Chartier, M. Herber, L. McDonald, C. Quentric, P. Barthélémy, M-O. Grimm
Published 2020-11-01